A combined model of insulin-like growth factor-binding protein-2 (IGFBP-2), lecithin cholesterol acyltransferase (LCAT), and CA125 outperformed CA125 detection alone for the earlier detection of ovarian cancer in terms of the sensitivity. This evidence concerns the gene IGFBP2 and ovarian cancer.